Viewing Study NCT03275051


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-05-29 @ 2:37 PM
Study NCT ID: NCT03275051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-11-23
First Post: 2017-08-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)
Sponsor: IRCCS San Raffaele
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Beta Thalassaemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Beta Thalassaemia View
None previously GSK2696277 View
None Lentiviral vector View
None TIGET-BTHAL View
None Gene therapy View